HomeATNM • NYSEAMERICAN
add
Actinium Pharmaceuticals Inc
Previous close
$1.00
Day range
$0.97 - $1.02
Year range
$0.95 - $1.95
Market cap
30.92M USD
Avg Volume
123.04K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.41M | -14.54% |
Net income | -5.94M | 10.70% |
Net profit margin | — | — |
Earnings per share | -0.19 | 9.52% |
EBITDA | -6.37M | 14.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 48.00M | -34.16% |
Total assets | 51.78M | -32.67% |
Total liabilities | 43.94M | -0.45% |
Total equity | 7.83M | — |
Shares outstanding | 31.37M | — |
Price to book | 3.98 | — |
Return on assets | -29.71% | — |
Return on capital | -131.14% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.94M | 10.70% |
Cash from operations | -5.29M | 8.03% |
Cash from investing | -104.00K | — |
Cash from financing | -3.00K | 0.00% |
Net change in cash | -5.39M | 6.33% |
Free cash flow | -13.65M | -273.72% |
About
CEO
Founded
2000
Website
Employees
25
